Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Single-cell transcriptome profiling of tumour tissue isolates allows the characterization of heterogeneous tumour cells along with neighbouring stromal and immune cells. Here we adopt this powerful approach to breast cancer and analyse 515 cells from 11 patients. Inferred copy number variations from the single-cell RNA-seq data separate carcinoma cells from non-cancer cells. At a single-cell resolution, carcinoma cells display common signatures within the tumour as well as intratumoral heterogeneity regarding breast cancer subtype and crucial cancer-related pathways. Most of the non-cancer cells are immune cells, with three distinct clusters of T lymphocytes, B lymphocytes and macrophages. T lymphocytes and macrophages both display immunosuppressive characteristics: T cells with a regulatory or an exhausted phenotype and macrophages with an M2 phenotype. These results illustrate that the breast cancer transcriptome has a wide range of intratumoral heterogeneity, which is shaped by the tumour cells and immune cells in the surrounding microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Limited T-cell recruitment and function in the TME correlates with poor prognosis in BC (21,22).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709 · cited 1×
“4.0b (default parameters) 55 , and relative gene expression was quantified as transcript per million (TPM) using RSEM v1.”
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
GSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440 · cited 1×
“To assess gene expression signatures and pathway activation, a non-parametric and unsupervised software algorithm called GSVA software in the R package 58 with the RNA-seq mode was used.”
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R., Garimella, K. V., Maguire, J. R., Hartl, C., Philippakis, A. A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,456
Inferring tumour purity and stromal and immune cell admixture from expression data
Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778 · cited 1×
“To further delineate the identity of carcinoma and non-carcinoma cells, we analysed the expression of tumour-associated stromal or immune gene sets proposed in the tumour purity estimation, ESTIMATE 26 .”
Cited by
Items 701–800 of 999
Pang, B., Quan, F., Ping, Y., Hu, J. R., Lan, Y., & Pang, L. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.633455 · Cited by 4
“…metastasis are the late events during the course of multi-step tumor progression (Lambert et al., 2017), which result in the vast majority of deaths from cancer (Coghlin and Murray, 2010), we seek to identify critical factors, especially lncRNAs, that are involved in the regulation of GBM invasion.”
BackgroundBreast cancer immunotherapy: Current biomarkers and the potential of in vitro assays
Skala, M. C., Ayuso, J. M., Burkard, M. E., & Deming, D. A. (2021) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2021.100348 · Cited by 4
Yang, Y., Shi, L., Zhang, J., Zheng, Y., Wu, G., Sun, J., Liu, M., Chen, Z., Wang, Y., Ji, R., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.926404 · Cited by 5
Damiani, C., Maspero, D., Filippo, M. D., Colombo, R., Pescini, D., Graudenzi, A., Westerhoff, H. V., Alberghina, L., Vanoni, M., & Mauri, G. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/256644 · Cited by 4
“Indeed, the former population is more heterogeneous than the latter [4].”
BackgroundMethodMetabolic landscape of the tumor microenvironmentPreprint
Xiao, Z., Dai, Z., & Locasale, J. W. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/527952 · Cited by 4
Zhou, B., Liu, S., Wu, L. L., Sun, Y., Chen, J., & Liu, S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.22.002824 · Cited by 4
“, 2018), and breast cancers(Chung et al., 2017).”
BackgroundYang, W., Xu, Z., Luo, M., Cai, Y., Xu, C., Wang, P., Wei, S., Xue, G., Jin, X., Cheng, R., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.11.516061 · Cited by 4
Regulation of Stromal Cells by Sex Steroid Hormones in the Breast Cancer Microenvironment
Yamaguchi, M., Takagi, K., Sato, A., Yamazaki, Y., Miyashita, M., Masamune, A., & Suzuki, T. (2024) · Cancers · doi:10.3390/cancers16234043 · Cited by 4
“Regarding the regulation of macrophage function, analysis of tumors from the TCGA and METABRIC databases suggests that ER+ cancers are more likely to express an M2 macrophage signature, while TNBCs exhibit higher M1 polarization [66], a finding supported by single-cell RNA sequencing analyses [67].”
Gu, Y., Feng, Z., Xu, X., & Jin, L. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03589-7 · Cited by 8
Liu, W., & Zhao, Z. (2025) · Bioinformatics · doi:10.1093/bioinformatics/btaf090 · Cited by 3
“The production and response to cytokines, which play critical regulatory roles, have been extensively studied in numerous diseases, including COVID-19 (Ren et al. 2021, Liu et al. 2022), rheumatoid arthritis (Zhang et al. 2019), and cancers (Chung et al. 2017, Garris et al. 2018).”
Ramirez, A., Orcutt-Jahns, B. T., Pascoe, S., Abraham, A. A., Remigio, B., Thomas, N., & Meyer, A. S. (2025) · Cell Systems · doi:10.1016/j.cels.2025.101294 · Cited by 5
Xuan, D. T. M., Nguyen, D. P. Q., Tram, V. T. N., & Ta, H. D. K. (2025) · Methods · doi:10.1016/j.ymeth.2025.06.007 · Cited by 3
Ma, T., Wang, Z., Zhou, Z., Wang, Y., Ma, T., Liu, X., Mao, Y. K., & Wang, H. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07877-6 · Cited by 3
Garay-Canales, C. A., Mendoza, M. S., Rodríguez-Santiago, Y., Castro, K. E. N., Ríos-Avila, M. D. S., López, G. E. Á., de León, V. V. P., Ruiz-Antonio, D. L., Zavala-López, C. A., Léon, C. G. D., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1735300 · Cited by 4
Wang, H. J., Shi, G., Liu, X., Zhang, J., Chen, S., Shi, J., Li, Y., Yue, G., & Wu, Y. (2026) · Expert Systems · doi:10.1111/exsy.70259 · Cited by 8
“It is also a cornerstone tool in single-cell sequencing (scRNA-seq and CyTOF) analyses for revealing cellular heterogeneity and immune cell subpopulations (Kobak and Berens 2019; Chung et al. 2017).”
Guo, L., Ma, X., Li, H., Yan, S., Zhang, K., & Li, J. (2024) · Molecular and Clinical Oncology · doi:10.3892/mco.2024.2747 · Cited by 3
“However, there is significant intratumoral heterogeneity in immune cell infiltration (16).”
BackgroundExtracellular vesicles as modulators of monocyte and macrophage function in tumors
Almeida, P. P., Moraes, J. A., Barja‐Fidalgo, C., & Renovato‐Martins, M. (2024) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202420231212 · Cited by 5
BreCML: identifying breast cancer cell state in scRNA-seq via machine learning
Ke, S., Huang, Y., Wang, D., Jiang, Q., Luo, Z., Li, B., Yan, D., & Zhou, J. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1482726 · Cited by 4
Classification of Breast Cancer Through the Perspective of Cell Identity Models
Iggo, R. D., & MacGrogan, G. M. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-70875-6_11 · Cited by 4
Advancements in proteogenomics for preclinical targeted cancer therapy research
Suo, Y., Song, Y., Wang, Y., Liu, Q., Rodriguez, H., & Zhou, H. (2025) · Biophysics Reports · doi:10.52601/bpr.2024.240053 · Cited by 6
“Single-cell omics data provide a more intuitive representation of the cellular composition within the TME (Bärthel et al. 2023; Cao et al. 2023; Christodoulou and Zaravinos 2023; Chung et al. 2017; Gessain et al. 2024).”
A semi-supervised non-negative matrix factorization model for scRNA-seq data analysis
Lan, J., Zhuo, X., Ye, S., & Deng, J. (2025) · Applied Soft Computing · doi:10.1016/j.asoc.2025.112982 · Cited by 3
MRAS: Master Regulator Analysis of Alternative Splicing
Zhou, L., Huang, Y., Zhao, Y., Guo, D. H., Xiao, W., Xu, R., Lv, X., Wu, S., Jing, S., & Liu, Z. (2025) · Advanced Science · doi:10.1002/advs.202414493 · Cited by 5
The Single-Cell Sequencing: A Dazzling Light Shining on the Dark Corner of Cancer
Li, J., Yu, N., Li, X., Cui, M., & Guo, Q. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.759894 · Cited by 3
“immunosuppressive: Tregs can experience immune anergy and exhibit co-mutation of CTLA4, TIGHT, and GITR genes, and macrophages can take on an M2 phenotype (78, 79).”
BackgroundSCAFG: Classifying Single Cell Types Based on an Adaptive Threshold Fusion Graph Convolution Network
Peng, H., Li, Y., & Zhang, W. (2022) · Mathematics · doi:10.3390/math10183407 · Cited by 3
Ye, Y., Luo, Y., Guo, T., Zhang, C., Sun, Y., Xu, A., Ji, L., Ou, J., & Wu, S. Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1179050 · Cited by 3
Essential procedures of single-cell RNA sequencing in multiple myeloma and its translational value
Du, J., Gu, X.-R., Yu, X., Cao, Y.-J., & Hou, J. (2023) · Blood Science · doi:10.1097/bs9.0000000000000172 · Cited by 3
“Unlike several solid tumor samples 8,9 that require mechanical dissociation and enzymatic digestion, MM is a tumor of the BM and blood system, and samples obtained from the peripheral blood (PB) and BM aspirates do not require much complicated processing to produce cell suspensions.”
BackgroundScLSTM: single-cell type detection by siamese recurrent network and hierarchical clustering
Jiang, H.-J., Huang, Y., Li, Q., & Feng, B. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05494-8 · Cited by 4
“To demonstrate the robustness and generalizability of ScLSTM, we apply it to the breast cancer single-cell data set supplied by Chung et al. [12].”
MethodChen, P., Liang, K.-F., Mao, X., Wu, Q., Chen, Z., Jin, Y., Lin, K., He, T., Yang, S., Huang, H., et al. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-06015-7 · Cited by 5
“…in multiple cancer types, including lung cancer (Lambrechts et al. 2018), pancreatic ductal adenocarcinoma (Elyada et al. 2019), breast cancer(Azizi et al. 2018; Chung et al. 2017; Gambardella et al. 2022) and esophageal squamous cell carcinoma (Zhang et al. 2021; Dinh et al. 2021).”
A Global Similarity Learning for Clustering of Single-Cell RNA-Seq Data
Zhu, X., Guo, L., Xu, Y., Li, H., Liao, X., Wu, F., & Peng, X. (2019) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm47256.2019.8983200 · Cited by 3
Uncoupling Traditional Functionalities of Metastasis: The Parting of Ways with Real-Time Assays
Varankar, S., & Bapat, S. A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070941 · Cited by 3
Cui, L., Wang, B., Ren, C., Wang, A., An, H., & Liang, W. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.648898 · Cited by 4
“Study uncovered how tumorgenesis and cancer cell immune escape and tumor cell heterogeneity (Chung et al., 2017; Zhao et al., 2020).”
BackgroundTIPD: A Probability Distribution-Based Method for Trajectory Inference from Single-Cell RNA-Seq Data
Xie, J., Yin, Y., & Wang, J. (2021) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-021-00445-4 · Cited by 3
Heterogeneity of estrogen receptor based on 18F-FES PET imaging in breast cancer patients
Hao, W., Li, Y., Du, B., & Li, X. (2021) · Clinical and Translational Imaging · doi:10.1007/s40336-021-00456-7 · Cited by 3
Du, B., Su, F., Wang, H., Liang, H., Song, X., Shao, Z., & Wei, Y. (2022) · Cancer Biomarkers · doi:10.3233/cbm-210271 · Cited by 3
Innate immunity as a target for novel therapeutics in triple negative breast cancer
Borgovan, T., Yanamandra, N., & Schmidt, H. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2096005 · Cited by 3
Tumor microenvironment and future targets of immunotherapy in breast cancer
Wang, Q., & Liu, Q. (2020) · Translational Breast Cancer Research · doi:10.21037/tbcr.2020.03.07 · Cited by 3
REBET: a method to determine the number of cell clusters based on batch effect removal
Fang, Z., Lin, C., Xu, Y., Li, H., & Xu, Q. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab204 · Cited by 3
“com fields such as oncology, developmental biology, microbiology and neuroscience [4, 5].”
BackgroundGenetic Heterogeneity Profiling by Single Cell RNA SequencingPreprint
Zhou, Z., Xu, B., Minn, A. J., & Zhang, N. R. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/457622 · Cited by 3
“Analysis of scRNA-seq dataset of primary breast cancer. a DENDRO cluster result for primary breast cancer dataset (Chung et al., 2017). b Hierarchical clustering result for the same dataset based on expression (logTPM).”
BackgroundAbaffy, P., Lettlová, S., Truksa, J., Kubista, M., & Šindelka, R. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/824714 · Cited by 3
Microfluidics for Immuno‐oncology
Ma, C., Harris, J., Morales, R. T., & Chen, W. (2019) · Wiley eBooks · doi:10.1002/9783527818341.ch5 · Cited by 5
Murillo, O. D., Petrosyan, V., LaPlante, E. L., Dobrolecki, L. E., Lewis, M. T., & Milosavljevic, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.06.498858 · Cited by 3
“To investigate these possibilities, we leveraged a publicly available single cell RNA-seq dataset (GSE75688) that includes single cell RNA sequencing for breast cancer patients, as well as pooled single cell sequencing and bulk sequencing (Chung et al., 2017).”
MethodNoh, S. U., Lim, J., Shin, S.-W., Kim, Y., Park, W., Batinic̈‐Haberle, I., Choi, C., & Park, W. (2024) · Preprints.org · doi:10.20944/preprints202402.0355.v1 · Cited by 3
Self-citationSpatiotemporal dynamics of tumor microenvironment remodelingPreprint
Lisek, K., Pentimalli, T. M., Theurillat, I., Beier, S., León-Periñán, D., Boltengagen, A., Antonatou, A., Cheytan, T., Dubnov, S., Müller, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.15.662972 · Cited by 3
Li, M., Wu, X., Jiang, L., Liu, M., Yanju, G., Li, X., Fan, T., Fan, Y., Wang, J., Wang, S., et al. (2025) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12527 · Cited by 2
“14,15 18 However, studies on the biological mechanisms implicated in both AD and lung cancer from a single-cell sequencing perspective are lacking.”
AJGM: joint learning of heterogeneous gene networks with adaptive graphical model
Yang, S., Hu, L., Chen, P., Zeng, X., & Mao, S. (2025) · Bioinformatics · doi:10.1093/bioinformatics/btaf096 · Cited by 2
“The data utilized in this study are obtained from single-cell RNA sequencing data of 220 TNBC cells (Chung et al. 2017), accessible from the GEO database (ID: GSE75688).”
The Role of HSP70 in Regulation of Breast Cancer Stem Cells and Apoptotic Pathway
Ozcan, G., & Körkaya, H. (2025) · Biochemistry · doi:10.5772/intechopen.1009789 · Cited by 2
Cell membrane vaccine delivery system: A review of the recent advances against breast cancer
Hilles, A. R., Mahmood, S., Widodo, R. T., Azemi, A. K., Nordin, A. H., Norpi, A. S. M., Jalil, M. F. A., Sofian, Z. M., Mohamed, M., Hambali, K. A., et al. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125849 · Cited by 2
NF-κB epigenetic attractor landscape drives breast cancer heterogeneity
Lopes, F. J. P., Pires, B. R. B., Lima, A. A. B., Binato, R., & Abdelhay, E. S. F. W. (2025) · npj Systems Biology and Applications · doi:10.1038/s41540-025-00611-0 · Cited by 4
Zhang, X., Sun, Y., Wu, D., Yu, F. F., Yang, H., Ye, X., Juying, W., Zhang, X., Zhu, Y., Lv, Y., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-025-08212-9 · Cited by 2
Zhou, J., Huang, Y., Li, G., Zhao, Z., Deng, Y., Xian, S., Hu, Y., Yi, M., & Liu, L. (2026) · Scientific Reports · doi:10.1038/s41598-026-39715-w · Cited by 2
“Finally, a total of 16,358 kidney-relative genes were used for next filter 54 .”
Zhang, M., Wang, H., Zhang, D., & Xu, S. (2026) · SLAS TECHNOLOGY · doi:10.1016/j.slast.2026.100432 · Cited by 2
Breast Cancer: Epidemiology, Molecular Classification, Diagnostics and Evolving Treatment Paradigms
Unuofin, J. O., Adefisan, A. O., Paimo, O. K., Maphetu, N., & Lebelo, S. L. (2026) · Molecules · doi:10.3390/molecules31142551 · Cited by 5
Li, S. C., Luo, J., & Lee, K. L. (2019) · Online Journal of Complementary & Alternative Medicine · doi:10.33552/ojcam.2019.01.000514 · Cited by 2
Pediatric Sarcomas: The Next Generation of Molecular Studies
Giannikopoulos, P., & Parham, D. M. (2022) · Cancers · doi:10.3390/cancers14102515 · Cited by 6
Deconvolution of cancer cell states by the XDec-SM method
Murillo, O. D., Petrosyan, V., LaPlante, E. L., Dobrolecki, L. E., Lewis, M. T., & Milosavljevic, A. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011365 · Cited by 5
Zatorski, N., Sun, Y., Elmas, A., Dallago, C., Karl, T., Stein, D., Rost, B., Huang, K.-L., Walsh, M., & Schlessinger, A. (2024) · iScience · doi:10.1016/j.isci.2024.110640 · Cited by 2
“(4) where TP is true positives and FP is false positives, recall Eq.”
Amin, M. T., Coussement, L., & Meyer, T. D. (2024) · Biomolecules · doi:10.3390/biom14121598 · Cited by 3
Yuan, H., Liang, X., Zhang, X., & Cao, Y. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42218 · Cited by 4
Inferring tumor purity using multi-omics data based on a uniform machine learning framework MoTP
Lu, Q., Liu, Z., & Wang, X. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf056 · Cited by 2
Wei, S., Lu, Y., Wang, P., Li, Q., Shuai, J., Zhao, Q., Lin, H., & Peng, Y. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06263-2 · Cited by 2
“By facilitating the analysis of functional and expression heterogeneity between individual cells, scRNA-seq allows for a deeper understanding of the diverse roles cells play in biological processes [10–14].”
Bristy, N. A., & Schwartz, R. S. (2024) · Bioinformatics Advances · doi:10.1093/bioadv/vbaf234 · Cited by 2
“We further demonstrate with application to a previously published DNA/RNA breast cancer data set (Chung et al. 2017) that TUSV-INT is practical on real data and can yield improvements in clonal deconvolution and lineage reconstruction capable of driving novel biological discovery.”
Patient-Derived Breast Cancer Tissue Cultures for Anti-Endocrine Drug Assays
Domenici, G., Trindade, G., Estrada, M. F., Cartaxo, A. L., Alves, P. M., André, S., & Brito, C. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2513-2_2 · Cited by 2
Li, X., Zhang, S., & Wong, K. (2020) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2020.2971993 · Cited by 3
Environmental Carcinogenesis at the Single-Cell Level
Chang, G., Saeki, K., Mori, H., & Chen, S. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-1364 · Cited by 2
A compendium of single cell analysis in aging and disease
Chintapula, U. K., Iqbal, S. M., & Kim, Y. (2020) · AIMS molecular science · doi:10.3934/molsci.2020004 · Cited by 3
Cancer research driven by cutting-edge multi-disciplinary technologies
Lyu, Q., Feng, Y., Shi, R., Wu, J., & Han, W. (2020) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2020-0638 · Cited by 2
Self-citationSingle Cell Genomics for Tumor Heterogeneity
Lee, H., & Park, W. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9620-6_10 · Cited by 2
Self-citationHuang, M., Yang, Y., Wen, X., Xu, W., Lü, N., Sun, X. S., Tu, J., & Lu, Z. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab581 · Cited by 4
“The elaborate atlas of single cells has shed light on multiple biological questions like revealing new cell types in cancers (6,7), investigating the dynamics of developmental processes (8), linkage and developmental trajectory of immune cells in cancer (9) and generating spatial transcriptomics landscape (10,11).”
BackgroundLi, G., Yang, M., Ran, L., & Jin, F. (2022) · Journal of Radiation Research and Applied Sciences · doi:10.1016/j.jrras.2022.05.016 · Cited by 3
Sharif, P. M., Khoshbin, A. P., Nasrollahzadeh, E., Keshavarz‐Fathi, M., & Rezaei, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818006-8.00003-7 · Cited by 8
Cordero, Á., Santamaría, P. G., & González‐Suárez, E. (2023) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-023-09530-4 · Cited by 2
Tumor immune microenvironment permissive to metastatic progression of ING4-deficient breast cancer
Tsutsumi, E., Macy, A. M., Lobello, J. R., Hastings, K. T., & Kim, S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304194 · Cited by 2
Self-citationImproved Spectral Clustering Method for Identifying Cell Types from Single-Cell Data
Li, Y., Luo, P., Lu, Y., & Wu, F. (2019) · Lecture notes in computer science · doi:10.1007/978-3-030-26969-2_17 · Cited by 2
Single-Cell Multiomics: Dissecting Cancer
Sambath, J., Patel, K., Limaye, S. A., & Kumar, P. (2020) · Algorithms for intelligent systems · doi:10.1007/978-981-15-2445-5_14 · Cited by 2
Deconvolute Gene Expression Based on Deep Learning in Scrna-Seq
Lv, X., Liu, Z., Li, D., Chen, X., Yang, Y., Li, X., & Shi, Q. (2021) · International Conference on Computational Intelligence and Security (CIS) · doi:10.1109/cis54983.2021.00023 · Cited by 2
Bosisio, F. M., Antoranz, A., Herck, Y. V., Bolognesi, M. M., Marcelis, L., Chinello, C., Wouters, J., Magni, F., Alexopoulos, L. G., Stas, M., et al. (2020) · eLife · doi:10.7554/elife.53008.sa2 · Cited by 3
Pre-metastatic niche drives breast cancer invasion by modulating MSC homing and CAF differentiationPreprint
Saxena, N., Bhardwaj, G., Jadhav, S., Zafar, H., & Sen, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.12.426460 · Cited by 2
“In order to evaluate if the stromal component of TNBCs harbour MSCs that contribute to higher invasiveness observed in TNBC, we analyzed scRNAseq data from 551 cells that were sampled from 11 breast cancer patients [26].”
MethodWu, G., Guo, W., Zhu, S., & Fan, G. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.15.464475 · Cited by 2
“The latest progress in scRNA-seq has facilitated the transcriptional classification of many malignant tumour cell types, including breast cancer, lung cancer and pancreatic ductal adenocarcinoma [12] [13].”
BackgroundObradović, A., Tomassoni, L., Yu, D., Guillan, K. C., Souto, K., Fraser, E., Bates, S. E., Drake, C. G., Saenger, Y. M., Cruz, F. S. D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.28.482410 · Cited by 4
SMURF: embedding single-cell RNA-seq data with matrix factorization preserving self-consistencyPreprint
Wang, B., Pu, J., Chen, L., & Li, S. C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.22.489140 · Cited by 2
Liu, Q., Zhang, S., Wang, Q., Tian, X., Zhang, N., Li, L., Wang, S., Lv, B., & Jiang, S. (2023) · Research Square · doi:10.21203/rs.3.rs-2721118/v1 · Cited by 2
Multi-scale characterisation of homologous recombination deficiency in breast cancerPreprint
Jacobson, D. H., Shi, P., Fisher, J., & Secrier, M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.23.554414 · Cited by 2
Yates, J., Kraft, A., & Boeva, V. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.24.620025 · Cited by 2
“Specifically, we utilized two datasets with paired single-cell and bulk data: the breast cancer datasets from Wu et al. [25], sequenced using 10X technology, and Chung et al. [30], sequenced using Smart-seq2.”
MethodResultOmics Applications in Cancer Immunology
Braicu, C., Bica, C., Pop, L., Zănoagă, O., Chiroi, P. A., Ciocan, C. A., Nutu, A. M., & Berindan‐Neagoe, I. (2024) · Springer eBooks · doi:10.1007/978-3-030-80962-1_311-1 · Cited by 1
Epigenetic abnormalities and neuroendocrine differentiation in prostate cancer
Kovchenko, G. A., Sivkov, A. V., Lyubchenko, L. N., & Каприн, А. Д. (2025) · Siberian Journal of Oncology · doi:10.21294/1814-4861-2025-24-1-115-124 · Cited by 1
Li, Y., Chen, C., Li, W., Shao, M., Dong, Y., & Zhang, Q. (2025) · American journal of clinical and experimental immunology. · doi:10.62347/xpcm9169 · Cited by 2
Driver Gene Detection via Causal Inference on Single Cell Embeddings
Cheng-bo, F., & Cheng, L. (2025) · Lecture notes in computer science · doi:10.1007/978-3-031-89704-7_10 · Cited by 1
Wang, Q., Cheng, L., Yan, H., & Yuan, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136135 · Cited by 2
“It is worth noting that although T cells and DCs are generally considered to exhibit genomic stability, minor CNV-like signals may still emerge due to transcriptional noise or stress-induced fluctuations in gene expression, as previously reported [19,20].”
UNC93B1: a novel immune−related prognostic biomarker in breast cancer
Tian, L., Zeng, H., Tian, L., Wang, H., & Liu, W. Y. (2025) · Discover Oncology · doi:10.1007/s12672-025-03124-8 · Cited by 2
“For example, immune checkpoint inhibitors have demonstrated significant clinical efficacy [34].”
Tumour Single‐Cell Bioinformatics: From Immune Profiling to Molecular Dynamics
Li, J. S., Ji, Z. Z., Zhang, A. Q., Ng, C. S. H., Qiao, G., Zhang, D., Li, C., Zhang, Q., To, K., & Tang, P. M. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70783 · Cited by 1
“For instance, an early study by Chung et al. conducted scRNA-seq of 515 cells from 11 breast cancer patients, identifying three main groups of immune cells, which were B cells, T cells and macrophages [19].”
Tumor Microcirculation: Abnormalities and Normalization
Fukumura, D. (2025) · Physiology in health and disease · doi:10.1007/978-3-031-99609-2_13 · Cited by 1
Niu, X., Guo, A., Liu, X., Li, H., Ji, H., & Wang, C. (2025) · Discover Oncology · doi:10.1007/s12672-025-04220-5 · Cited by 1
Liu, Y., Zhang, Z., Qui, M., Wang, S., Salim, F. D., Shen, J., Chen, T., Razzak, I., Li, F., & Bian, J. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag330 · Cited by 1
“Single-cell RNA sequencing (scRNA-seq) has become a key technology for profiling transcriptomes at cellular resolution and for dissecting heterogeneous tissues, developmental processes, and disease-associated cell states [ 1– 3].”
Li, X. Y., & Gao, L. (2025) · Life Conflux · doi:10.71321/dz9d7b09 · Cited by 2
“…insights into how the virus evades immune sur-Life veillance and enhances viral replication by modulating the host cell transcriptomic profile [13 -14]. dupli-A Furthermore, compared to conventional bulk sequencing methodologies, SCS technology enables the identification of intercellular…”
Yao, H., Cao, Z., Wang, Z., Ni, X., Dong, J., Cai, H., Han, Y., & Luo, X. (2025) · Proceedings · doi:10.1109/icdm65498.2025.00179 · Cited by 1
The Role of B Cells in Tumorigenesis and Immunotherapy
Yin, G., Qi, L. N., Kang, N., Li, T., Li, C., Liu, Y. E., Ye, J., & Liu, W. (2026) · Immune Network · doi:10.4110/in.2026.26.e14 · Cited by 2
He, L., Zhao, Q., Chen, Z., He, L., Qi, Z., Wu, J., Zhou, K., & Cui, Y. (2026) · Human Cell · doi:10.1007/s13577-026-01384-2 · Cited by 1
“A prior study employing scRNA-seq distinguished between cancerous and non-cancerous cells in samples obtained from patients with breast cancer, revealing both common features within tumors and heterogeneity regarding breast cancer subtypes and key cancer-related pathways [8].”
Novel biomarkers in breast cancer for precision therapy and adaptive treatment strategies
Dai, D., & Micsik, T. (2026) · Advances in Translational Research · doi:10.1556/1661.2026.00016 · Cited by 4
Wang, D., Dai, Q., Guo, J. Z., Li, D., Guo, C., Ma, P., Wen, F., Tong, X., Gong, C., Cheng, H.-Y., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74954-5 · Cited by 1
Hu, D., Zhang, F., Wang, Z., Jing, Y., Yee, P. L., Lu, T., Zhao, Y. Q., Cui, X., Yuan, S., & Wang, C. (2026) · Archives of Computational Methods in Engineering · doi:10.1007/s11831-026-10709-1 · Cited by 1
Metadata
- Authors
- Chung, W., Eum, H. H., Lee, H.-O., Lee, K.-M., Lee, H.-B., Kim, K.-T., Ryu, H. S., Kim, S., Lee, J. E., Park, Y. H., Kan, Z., Han, W., & Park, W.-Y.
- Affiliations
- Samsung Medical Center (KR)
- Seoul National University (KR)
- Pfizer (United States) (US)
- Corresponding author
- Han, Wonshik
- Park, Woong-Yang
- ORCID
- Venue
- Nature Communications
- Published
- 2017-05-05
- Volume
- 8
- Issue
- 1
- Pages
- 15081-15081
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5424158
- OpenAlex
- W2610509384
- Cited by
- 992
- References
- 62
- Citations by year
- 2026: 57 · 2025: 85 · 2024: 116 · 2023: 117 · 2022: 148 · 2021: 191 · 2020: 106 · 2019: 93 · 2018: 63 · 2017: 11
- FWCI
- 30.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation
- National Research Foundation of Korea (2015R1A2A2A01008264, 2016R1A5A1011974)
- Samsung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- breast cancer, intratumoral heterogeneity, tumor immune microenvironment, tumor stroma, T cells, B cells, macrophages, regulatory T cells, T cell exhaustion, M2 macrophages, tumor subtypes, tumor transcriptome, copy number variation
- MeSH terms
- Exome Sequencing, B-Lymphocytes, Breast Neoplasms, Female, Humans, Lymph Nodes, Macrophages, Receptors, Estrogen, Receptors, Progesterone, T-Lymphocytes, Lymphocytes, Tumor-Infiltrating, Sequence Analysis, RNA, Carcinoma, Ductal, Breast, Erb-b2 Receptor Tyrosine Kinases, Receptor, ErbB-2, Gene Expression Profiling, DNA Copy Number Variations, Single-Cell Analysis, Tumor Microenvironment, Triple Negative Breast Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.